Newsroom

        

Q atar Foundation established Qatar National Research Fund (QNRF) in 2006 as part of its ongoing commitment to establish Qatar as a knowledge-based economy. Qatar Foundation views research as essential to national and regional growth; as the means to diversify the nation’s economy, enhance educational offerings and develop areas that affect the community, such as health and environment. 

Qatar National Research Fund aims to foster original, competitively selected research in More...


 

  • Time Zone: Arabia Time Zone UTC+03:00
  • Address: PO Box 5825, Doha, Qatar



أنشأت مؤسسة قطر الصندوق القطري لرعاية البحث العلمي عام 2006 كجزء من التزامها المستمر بإقامة الاقتصاد القائم على المعرفة في دولة قطر. وتولي مؤسسة قطر للبحوث أهمية قصوى استنادًا إلى دورها الحيوي في تحقيق النمو سواء داخل قطر أو على الصعيد الإقليمي، وكونها وسيلة لتنويع اقتصاد البلاد، وتعزيز الفرص التعليمية، وتطوير المجالات المؤثرة في المجتمع كالصحة والبيئة.

ويهدف الصندوق القطري لرعاية البحث العلمي إلى تشجيع الأبحاث المبتكرة المختارة على أساس تنافسي في

المزيد ...


  • التوقيت: توقيت غرينتش +3
  • صندوق البريد: 5825 الدوحة, قطر
  • فاكس: 8079 4454 974
  • الدعم الفني: support.qnrf.org
  • الموقع الالكتروني: www.qnrf.org

Tuesday, September 26, 2023 9:03 PM Doha Time

QNRF-funded researchers find herpes virus rates falling in Asia
QNRF PR
/ Categories: In the Media

QNRF-funded researchers find herpes virus rates falling in Asia

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have found that more than one in 10 of the population in Asia is infected with the herpes simplex virus type 2 (HSV-2), yet prevalence is declining by 2% yearly.

The study was conducted by the Infectious Disease Epidemiology Group (IDEG) at WCM-Q and WHO Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS and Sexually Transmitted Infections to address one of the goals of the WHO’s Global Health Sector Strategy on Sexually Transmitted Infections. The study provided the first detailed characterisation of HSV-2 epidemiology in Asia, including the WHO regions of Southeast Asia and the Western Pacific. Writing in the prestigious journal Lancet Regional Health — Western Pacific, the researchers said the virus was more common in women than men.

Sawsan AlMukdad, joint first author of the study and researcher at WCM-Q, said: “We applied state-of-the-art methodologies to assess HSV-2 epidemiology in Asia. We found that approximately one in every 10 individuals (12%) is infected with HSV-2 in Asia, but the prevalence is declining by 2% per annually. Prevalence increased gradually from 5% in people under 20 years of age, to 27% in those over 60, but women have a 70% higher prevalence rate compared to men.”

HSV-2 infection is a globally prevalent sexually transmitted infection, which can cause irritation and ulcers in the pelvic region. It is also linked to an increased risk of HIV acquisition and transmission.

Manale Harfouche, joint first author of the study and senior researcher at WCM-Q said: “HSV-2 infection was found to be the cause of 48% of cases where patients present with ulcers in the pelvic region, and 76% of genital herpes cases, highlighting the disease burden caused by this infection in Asia. Our findings fill a gap in our understanding of HSV-2 infection in the global context and provide insights about its epidemiology in this region with implications for the global epidemiology.”

Dr. Laith Abu-Raddad, principal investigator of the study and professor of population health sciences at WCM-Q, said: “In the context of there being no public health programs targeted to prevent and control HSV-2 transmission, this infection is widespread, with serious disease consequences. There is a need to expand and broaden HSV-2 research and surveillance and to accelerate ongoing efforts to develop HSV-2 vaccines.”

The study, entitled ‘Epidemiology of herpes simplex virus type 2 in Asia: A systematic review, meta-analysis, and meta-regression’, was conducted with funding from the Qatar National Research Fund through the National Priorities Research Program (NPRP 9-040-3-008) and by pilot funding from the Biomedical Research Program at Weill Cornell Medicine in Qatar.

Read more at The Peninsula.

Previous Article Invitation: Joint Research Outcome Seminar
Next Article Information Session about the Launch of the Second Cycle of the Rapid Response Call
Print
2484
«September 2023»
SunMonTueWedThuFriSat
272829303112
3456789
10111213141516
17181920212223
24252627282930
1234567

Archive